Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-136202
Filing Date
2024-12-13
Accepted
2024-12-13 16:15:16
Documents
1
Period of Report
2024-12-11

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6083
  Complete submission text file 0000950170-24-136202.txt   7473
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Issuer) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address
Watson David O. (Reporting) CIK: 0001657719 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38276 | Film No.: 241548522